REFERENCES
- Bonucci E, Sadun R. Dihydrotachysterol-induced aortic calcification. Clin Orthop 1975; 107: 283–294.
- Brickman JW, Hartenbower DL, Normal AW, Coburn JW. Action of 1-α-hydroxyvitamin D and 1.25-dihydroxyvitamin D on mineral metabolism in man. Effect on net absorption of phosphorus. Am J Clin Nutr 1977; 30: 1064–1069.
- Chertow BX, Baylink DJ, Wergedal JE, Su MHH, Normal AW. Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1.25-dihydroxycholecalciferol. J Clin Invest 1975; 56: 668–677.
- Ejerblad S, Eriksson J, Johansson H. Uraemic arterial disease. Scand J Urol Nephrol 1979; 13: 161–169.
- Frank A. Automated wet ashing and multi-metal determination in biological materials by atomic-absorption spectrometry. Z Anal Chem 1976; 279: 101–102.
- Frank A, Petersson LR. Selection of operating conditions and analytical procedure in multi-metal analysis of animal tissues by d.c. plasma-atomic emission spectroscopy. Spectrochim Acta, Part B 1983; 38: 302–307.
- Frank A, Petersson LR. To be published.
- Frey M, Janke J, Fleckenstein A. Inhibition of vitamin D-induced vascular calcification in rats by means of the Ca-antagonist Verapamil. Pflügers Archiv 1978; 377: R9.
- Goligorsky MS, Chaumovitz C, Jayson R, Goldstein J, Kol R. Calcium metabolism in uremic nephrocalcinosis: Preventive effect of Verapamil. Kidney Int 1985; 27: 774–779.
- Haut LL, Alfrey AC, Guggenheim S, Buddington B, Schrier N. Renal toxicity of phosphate in rats. Kidney Int 1980; 17: 722–731.
- Ibels LS, Alfrey AC, Huffer WE, Craswell PW, Weil R. Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med 1979; 66: 790–796.
- Ibels LS. The pathogenesis of metastatic calcification in uraemia. Prog Biochem Pharmacol 1980; 17: 242–250.
- Ibels LS, Alfrey AC, Huffer WE, Craswell PW, Weil R. Calcification in the end-stage kidneys. Am J Med 1981; 71: 33–37.
- Kanis JA, Brown CB, Cameron EC, Cundy T, Platts MM, Paterson A, Russell RGG. The role of vitamin D metabolites in the osteomalacia of renal disease. Curr Med Res Opin 1981; 7: 283–313.
- Krog M, Ejerblad S, Johansson H, Wilander E. Tissue calcification and alkaline phosphatase activity in uraemic rats. Scand J Urol Nephrol 1988; 22: 45–51.
- Krog M, Ejerblad S, Johansson H. The aortic content of glycosaminoglycans, hydroxyproline and calcium in experimental uraemia, with special reference to parathyroidectomy and vitamin D treatment. Scand J Urol Nephrol 1984; 18: 241–247.
- Kugai N, Yoshinobu K, Satoshi K, Yamashita K, Ogata E. Evidence for acute inhibitory effects in vivo of 1-α-hydroxycholecalciferol on parathyroid hormone secretion in rats. Endocrinology 1981; 109: 1078–1083.
- Lehr D. Causative relationships of parathyroid hormone to renogenic and reniprival cardiovascular disease. Ann NY Acad Sci 1973; 72: 901–969.
- Massry SG, Goldstein DA, Malluche HH. Current status of the use of 1.25 (OH)2 D3 in the management of renal osteodystrophy. Kidney Int 1980; 18: 409–418.
- Matthews JL, Martin JH, Carson FL. Ultrastructure of calciphylaxis in skin. Metab Bone Rel Res 1978; 1: 219–226.
- Morrison AB. Experimentally induced chronic renal insufficiency in the rat. Lab Invest 1962; 11: 321–332.
- Toda T, Leszczynski DE, Kummerow A. The role of 25-hydroxy-vitamin D in the induction of atherosclerosis in swine and rabbit by hypervitaminosis D. Acta Pathol Jpn 1983; 33: 37–44.
- Tvedegård E, Ladefoged O, Nielsen M, Kamstrup O. Effect of 1-α-Hydroxyvitamin D and dietary calcium and phosphate on the mineral content in rabbits with mild azotemia. Nephron 1983; 34: 185–191.
- Trout GE. Dissociation between serum calcium and the degree of mineralisation of the aorta. S Afr J Med Sci 1957; 22: 157–158.
- Wadkins CL, Luben R, Thomas M, Humphreys R. Physical biochemistry of calcification. Clin Orthop 1974; 99: 246–266.